Biosimilar denosumab of Alkem (Denuril) showed comparable efficacy, safety, pharmacokinetics, pharmacodynamics, and ...

Sandoz sues Amgen in U.S. court over Enbrel patents, alleging efforts to block biosimilar Erelzi and delay competition in the ...

Denosumab works by specifically targeting the RANK ligand (RANKL), a critical protein in the lifecycle of osteoclasts, the ...

Pune: The final report by a committee of the Sassoon General Hospital into the death of a pregnant woman who had been ...

and the bone disease treatments 'Stoboclo' and 'Osenvelt' (Denosumab). 'Eydenzelt' is a biosimilar of Regeneron's Eylea and is approved for the treatment of myopic choroidal neovascularization.

Novartis' soon-to-be-divested Sandoz unit has positive clinical trial data in hand for a biosimilar of Amgen's blockbuster osteoporosis therapy Prolia (denosumab), clearing the way for regulatory ...

Rodolfo Hrosz has chosen to step down from his position as Managing Director of the company, effective April 30. He will be ...

Stocks like TARC, Bharti Hexacom, Infosys, Aurobindo Pharma, Bharat Heavy Electricals, Bank of India, Tata Steel, Sanofi ...

CuraTeQ Biologics, a subsidiary of the company, has successfully concluded the Phase 1 study assessing the pharmacokinetics (PK) and pharmacodynamics (PD) of its denosumab biosimilar, BP16.

TCS, Adani Energy Solutions, Tata Steel, BPFC, BHEL, Glenmark Pharma, Sun Pharma, Biocon, Bharti Hexacom, Bansal Wire, Taj ...

The broader markets are higher, with the Nifty Midcap 100 gaining 2.03 per cent, and the Nifty Smallcap 100 climbing 2.65 per ...